|
Randomized Controlled Trial
Citations 11-20 of 86 total displayed.
|
Past content
(since Nov 1998):
|
- Clinical Trials
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
- ADAPT Research Group
Arch Neurol 2008; 65: 896-905.
[Abstract]
[Full text]
[PDF]
- Correspondence
Notice of Failure to Disclose Financial Interest: "A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials" (Arch Neurol. 2007;64[9]:1323-1329)
- John Harrison
Arch Neurol 2008; 65: 992-a.
[Extract]
[Full text]
[PDF]
[ Original Article ]
- Original Contributions
Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
- Chitra Krishnan; Adam I. Kaplin; Robert A. Brodsky; Daniel B. Drachman; Richard J. Jones; Dzung L. Pham; Nancy D. Richert; Carlos A. Pardo; David M. Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C. McArthur; Avindra Nath; Benjamin M. Greenberg; Peter A. Calabresi; Douglas A. Kerr
Arch Neurol 65.8.noc80042.
[Abstract]
[Full text]
[]
- Clinical Trials
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
- ADAPT Research Group
Arch Neurol 2008.65.7.nct70006.
[Abstract]
[Full text]
[]
- Clinical Trials
Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations: The ADVANS Study
- Olivier Rascol; Werner Poewe; Andrew Lees; Marina Aristin; Laurence Salin; Nolwenn Juhel; Lisa Waldhauser; Thomas Schindler; for the ADVANS Study Group
Arch Neurol 2008; 65: 577-583.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
- Michael A. Schwarzschild; Steven R. Schwid; Kenneth Marek; Arthur Watts; Anthony E. Lang; David Oakes; Ira Shoulson; Alberto Ascherio; and the Parkinson Study Group PRECEPT Investigators
Arch Neurol 2008.65.6.nct70003.
[Abstract]
[Full text]
[]
- Clinical Trials
Effect of Low Concentrations of Apomorphine on Parkinsonism in a Randomized, Placebo-Controlled, Crossover Study
- Steven A. Gunzler; Caroline Koudelka; Nichole E. Carlson; Misha Pavel; John G. Nutt
Arch Neurol 2008; 65: 193-198.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial
- Alireza Minagar; J. Steven Alexander; Robert N. Schwendimann; Roger E. Kelley; Eduardo Gonzalez-Toledo; Joaquim J. Jimenez; Lucia Mauro; Wenche Jy; Stacy J. Smith
Arch Neurol 2008; 65: 199-204.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial
- Alireza Minagar; J. Steven Alexander; Robert N. Schwendimann; Roger E. Kelley; Eduardo Gonzalez-Toledo; Joaquim J. Jimenez; Lucia Mauro; Wenche Jy; Stacy J. Smith
Arch Neurol 2007.41.
[Abstract]
[Full text]
[]
- Clinical Trials
Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
- Amit Bar-Or; Timothy Vollmer; Jack Antel; Douglas L. Arnold; Caroline Anita Bodner; Denise Campagnolo; Jill Gianettoni; Farzaneh Jalili; Norman Kachuck; Yves Lapierre; Masaaki Niino; Joel Oger; Mary Price; Susan Rhodes; William H. Robinson; Fu-Dong Shi; Paul J. Utz; Frank Valone; Leslie Weiner; Lawrence Steinman; Hideki Garren
Arch Neurol 2007; 64: 1407-1415.
[Abstract]
[Full text]
[PDF]
|
|
